UCI Heads Study Investigating NeuroRX’s ZYESAMI™ (aviptadil) Investigating Ability to Reduce Progression to Critical COVID-19
During the pandemic, TrialSite has reported multiple times on the potential for NeuroRX’s RLF-100 (aviptadil) currently under investigation and accessible […]